SkinHealth Systems annual stock-based compensation
2019
2020
2021
2022
2023
2024
2025
SkinHealth Systems Stock-Based Compensation Growth & History (SKIN)
SkinHealth Systems's stock-based compensation was $14.8M for fiscal 2025.
View full SkinHealth Systems company overviewSkinHealth Systems annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $14.8M | −$11.9M | −44.47% |
| 2024 | 2024-12-31 | $26.7M | $4.2M | +18.42% |
| 2023 | 2023-12-31 | $22.5M | −$6.0M | −20.88% |
| 2022 | 2022-12-31 | $28.5M | $16.1M | +129.47% |
| 2021 | 2021-12-31 | $12.4M | $12.1M | +3320.94% |
| 2020 | 2020-12-31 | $363,000 | $260,000 | +252.43% |
| 2019 | 2019-12-31 | $103,000 | — | — |
SkinHealth Systems quarterly stock-based compensation
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.9M | −$2.4M | −45.46% |
| Q1 2026 | 2026-03-31 | $2.1M | −$1.4M | −40.19% |
| Q4 2025 | 2025-12-31 | $3.6M | −$2.3M | −38.72% |
| Q3 2025 | 2025-09-30 | $2.5M | −$5.3M | −68.17% |
| Q2 2025 | 2025-06-30 | $5.3M | −$1.2M | −18.31% |
| Q1 2025 | 2025-03-31 | $3.5M | −$3.2M | −47.62% |
| Q4 2024 | 2024-12-31 | $5.8M | $3.6M | +159.08% |
| Q3 2024 | 2024-09-30 | $7.7M | −$473,000 | −5.78% |
| Q2 2024 | 2024-06-30 | $6.5M | −$2.0M | −23.77% |
| Q1 2024 | 2024-03-31 | $6.6M | $3.1M | +85.52% |
| Q4 2023 | 2023-12-31 | $2.3M | −$5.4M | −70.36% |
| Q3 2023 | 2023-09-30 | $8.2M | $736,000 | +9.88% |
| Q2 2023 | 2023-06-30 | $8.5M | $2.1M | +33.65% |
| Q1 2023 | 2023-03-31 | $3.6M | −$3.5M | −49.26% |
| Q4 2022 | 2022-12-31 | $7.6M | $3.8M | +100.82% |
| Q3 2022 | 2022-09-30 | $7.4M | $2.4M | +46.58% |
| Q2 2022 | 2022-06-30 | $6.4M | $2.9M | +81.81% |
| Q1 2022 | 2022-03-31 | $7.0M | $7.0M | +20632.35% |
| Q4 2021 | 2021-12-31 | $3.8M | — | — |
| Q3 2021 | 2021-09-30 | $5.1M | $5.0M | +6586.84% |
| Q2 2021 | 2021-06-30 | $3.5M | — | — |
| Q1 2021 | 2021-03-31 | $34,000 | — | — |
| Q3 2020 | 2020-09-30 | $76,000 | — | — |
SkinHealth Systems stock-based compensation trends
Over the last five fiscal years, SkinHealth Systems's stock-based compensation increased from $363,000 to $14.8M, a change of $14.5M. The latest reported quarter, Q2 2026, shows $2.9M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review SkinHealth Systems source filings ↗